Next, we studied the in vivo effects associated with the transduction of RPS19-mutated DBA patient CD34+ cells with the therapeutic LVs; 100,000 CD34+ cells transduced with either LV were transplanted into immunodeficient NSG mice. Here, CD34 is linked to Diamond-Blackfan anemia.